期刊文献+

放射生物模型在乳腺癌放疗计划评价中的比较 被引量:7

Comparison of radiobiological models for evaluation of radiotherapy treatment planning of breast cancer
原文传递
导出
摘要 目的比较分析不同放射生物模型的特性,以寻求评价乳腺癌放疗计划合理的放射生物模型。方法比较预测放射性肺炎发生率和放射性心脏病死亡率的NTCP两种模型和TCP四种模型,计算相同DVH数据所得结果的差异;并分析同一模型中,输入DVH数据的形式、参数的选择等对结果的影响。结果假设全肺平均照射30Gy剂量时,NTCP-RSM模型预测的放射性肺炎发生率为32%,NTCP-Lyman模型预测的为54%。以发生放射性心脏病死亡率1%为例,NTCP-RSM模型对应的心脏平均照射剂量为28Gy,而NTCP-Lyman模型对应的为40Gy。应用LQ-Poisson-TCP模型、Pois-son-TCP模型、Logit-TCP模型和Zaider-TCP模型,计算相同DVH数据库的平均TCP分别为21.1%、38.4%、41.0%和80.8%(P=0.000)。采用不同栅格大小计算的NTCP/TCP结果差别较小。计算时采用物理剂量或LQED2剂量对NTCP/TCP结果有一定影响,采用物理剂量时的结果稍大。α和β值、肿瘤细胞密度、D50值和DVH简化方法对TCP的影响显著(P=0.000)。结论评价和优化乳腺癌放疗计划选择放射生物模型时,以NTCP-Lyman模型计算放射性肺炎和以NTCP-RSM模型计算放射性心脏病死亡率比较合理。TCP模型以LQ-Poisson-TCP模型比较符合临床实际。影响预测结果最大的是模型参数值的选取,选择时需要加以注意。这些模型目前有助于对不同治疗模式进行研究和比较,而不是给出对临床实际结果的精确预测。 Objective To find an appropriate radiobiological model for analyzing the biological effect of the radiotherapy for breast cancer by comparing different results computed by various types of radiobiological models. Methods DVHs database simulating breast conserving radiotherapy was set up, based on clinical DVHs data of the heart, the lung and PTV of 22 patients with early breast cancer given conventional tangential radiotherapy. Two models assessing NTCP of radiation pneumonitis and cardiac mortality and four models assessing TCP were compared by analyzing the effects of the parameters and DVH database input methods on the results. Results When mean irradiation close of the whole lung was 30 Gy,the incidence of radiation pneumonitis was 32% and 54% predicted by NTCP-RSM model and NTCP-Lyman model, respectively. When 1% cardiac mortality of radiation was assumed, 28 Gy and 40 Gy isodose should cover the heart assessed by the two models. The mean TCP were 21.1% ,80.8% ,38.4% and 41.0% when assessed by LQ-Poisson-TCP, Zaider-TCP, Poisson-TCP and Logit-TCP models, respectively. Setting various differential DVH(dDVH) bins had very few effect on the NTCP/TCP results in a certain model. Adopting physical dose or LQED2 affected the results with greater results for physical dose. Variation in α or β value, tumor cell density and D50 had significant effect upon TCP results in LQ-Poisson-TCP (P = 0. 000). Conclusions NTCP-Lyman model is better for predicting the incidence of radiation pneumonitis while NTCP- RSM model is better for predicting radiation-induced cardiac mortality. LQ-Poisson-TCP is the best TCP model for clinical application. Parameters selected for model can significantly affect the results. It is important to understand the distinct characteristics of different models.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2008年第4期293-297,共5页 Chinese Journal of Radiation Oncology
关键词 乳腺肿瘤 放射生物模型 比较分析 Breast neoplasms Radiobiologieal models Comparison analysis
  • 引文网络
  • 相关文献

参考文献15

  • 1Lyman JT,Wolbarst AB. Optimization of radiation therapy, Ⅲ : A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys,1987,13:103-109.
  • 2Gagliardi G,Lax I, Ottolenghi A,et al. Long-term cardiac mortality after radiotherapy of breast cancer-application of the relative seriality model. Br J Radiol,1996,69:839 -846.
  • 3Kallman P, Agren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol, 1992,62 : 249-262.
  • 4Zaider M, Minerbo GN. Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol,2000,45:279-293.
  • 5Okunieff P, Morgan D, Niemierko A, et al. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys, 1995,32:1227- 1237.
  • 6Burman C, Kuteher GJ, Emami B, et al. Fitting of nomlal tissue tolerance data to an analytic function, Int J Radiat Oneol Biol Phys, 1991,21 : 123-135.
  • 7Ghossein NA, Stacey P, Alpert RT, et al. Local control of breast cancer with tumorectomy plus radiotherapy or radiotherapy alone. Radiology, 1976,121:455-459.
  • 8Guerrero M, Li XA. Analysis of a large number of clinical studies for breast cancer radiotherapy : estimation of radiobiological parameters for treatment planning. Phys Med Biol,2003,48:3307-3326.
  • 9Cho BC, Schwarz M, Mijnheer B J, et al. Simplified intensity-modulated radiotherapy using pre-defined segments to reduce cardiac complications in left-sided breast cancer. Radiother Oncol,2004, 70:231-241.
  • 10Wheldon TE,Deehan C, Wheldon EG,et al. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. Radiother Oncol, 1998,46:285-295.

二级参考文献36

  • 1Chao KS,Deasy JO,Markman J,et al.A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy:initial results.Int J Radiat Oncol Biol Phys,2001,49:907-916.
  • 2Niemerko A,Goitein M.Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architeeture.Radiother Oncol,1991,20:166-176.
  • 3Jackson A.Partial irradiation of the rectum.Semin Radiat Oncol,2001,11:215-223.
  • 4Yorke ED,Kutcher GJ,Jackson A,et al.Probability of radiation-induced complicatiors in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation.Radiother Oncol,1993,26:226-237.
  • 5Yorke ED,Jackson A,Rosenzweig KE,et al.Dose-volume factors cnntributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.Int J Radiat Oncol Biol Phys,2002,54:329-339.
  • 6Wu Q,Mohan R,Niemierko A,et al.Optimization of intensity-modulated radiotherapy plans based on the equivalant uniform dose.Int J Radiat Oncol Biol Phys,2002,52:224-235.
  • 7Stavrev P.Inverse treatment planning by physically constrained minimization of a biological objeetive function.Med Phys,2003,30:2948-2958.
  • 8Jackson A,Skwarchuk MW,Zelefsky MJ,et al.Late rectal bleeding after conformal radiotherapy of prostate cancer (Ⅱ):volume effects and dose-volume histograms.Int J Radiat Oncol Biol Phys,2001,49:685-698.
  • 9Zelefsky MJ,Fuks Z,Hunt M,et al.High-dose intensity modulated radiation therapy for prostate cancer:early toxicity and biochemical outcome in 772 patients.Int J Radiat Oncol Biol Phys,2002,53:1111-1116.
  • 10Eisbruch A,Ship JA,Kim HM,et al.Partial irradiation of the parotid gland.Semin Radiat Oncol,2001,11:234-239.

共引文献12

同被引文献80

  • 1姚昱旻,刘卫国.Android的架构与应用开发研究[J].计算机系统应用,2008,17(11):110-112. 被引量:281
  • 2赵充,卢泰祥,韩非,卢丽霞,黄劭敏,邓小武,林承光,崔念基.139例鼻咽癌调强放疗的临床研究[J].中华放射肿瘤学杂志,2006,15(1):1-6. 被引量:154
  • 3徐晓娜,吴昊,韩树奎.左侧乳腺癌调强放疗的剂量学研究[J].中华放射肿瘤学杂志,2006,15(3):192-195. 被引量:40
  • 4杨瑞杰,戴建荣,胡逸民.放疗的生物学评估和优化[J].中华放射肿瘤学杂志,2006,15(3):172-175. 被引量:13
  • 5林少俊,陈传本,韩露,郑葳,陈梅,潘建基.鼻咽癌调强放射治疗230例初步结果[J].福建医科大学学报,2007,41(1):66-70. 被引量:61
  • 6Sultanem K, Shu H K, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma : The University of California San Francisco experience[ J ]. Int J Radiat Oncol Biol Phys, 2000, 48 (3) : 711-722.
  • 7Kam M K, Teo P M, Chau R M, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience [ J ]. Int J Radiat Oncol Biol Phys, 2004, 60(5) :1440-1450.
  • 8Wolden S L, Chen W C, Pfister D G, et al. Intensitymodulated radiation therapy ( IMRT ) for nasopharynx cancer : update of the Memorial Sloan Kettering experience [ J ] . Int J Radiat Oncol Biol Phys, 2006, 64( 1 ) :57-62.
  • 9ICRU Report 50 : Prescribing, recording, and reporting photon beam therapy [ S ] . Bethesda, MD : International Commission on Radiation Units and Measurements, 1993.
  • 10ICRU Report 62 : Prescribing, recording, and reporting photon beam therapy ( supplement to ICRU Report 50 ) [ S ] . Bethesda, MD: International Commission on Radiation Units and Measurements, 1999.

引证文献7

二级引证文献25

;
使用帮助 返回顶部